626 filings
Page 2 of 32
4
wzyhkcz
19 Mar 24
First Wave BioPharma / Sarah Romano ownership change
4:10pm
8-K
ykpx7bxz8ia5
18 Mar 24
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
4:40pm
DEFA14A
buoq49y4oepb
18 Mar 24
Additional proxy soliciting materials
4:31pm
4
xeoig382ylv
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:05pm
4
ptuw8v1ft5n4o6
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:05pm
3
lxmnacbt4ib
15 Mar 24
First Wave BioPharma / CHAITAN PHD KHOSLA ownership change
6:00pm
3
1zaeqhl343
15 Mar 24
First Wave BioPharma / Jack Syage ownership change
6:00pm
DEFA14A
5jj89
14 Mar 24
Additional proxy soliciting materials
6:10am
8-K
53no4ej75
14 Mar 24
Latiglutenase is a potentially first-in-class oral biotherapeutic for the treatment of celiac disease
6:09am
8-K
iij56
5 Mar 24
First Wave BioPharma, Inc. to raise approximately $4.0 million of Gross Proceeds in Registered Direct Offering
5:26pm
424B5
ldmojb1ndmp0fyzqg
4 Mar 24
Prospectus supplement for primary offering
5:29pm
SC 13G/A
5kl ebd4qd16by
14 Feb 24
First Wave BioPharma / ARMISTICE CAPITAL ownership change
2:45pm
424B3
loe69
18 Jan 24
Prospectus supplement
4:01pm
EFFECT
nogt d7b92s8iz20dw
18 Jan 24
Notice of effectiveness
12:15am
4
0atazh2hfzq3cgni648b
17 Jan 24
First Wave BioPharma / Sarah Romano ownership change
4:02pm
4
fyxvsabr2 1kens3srtk
17 Jan 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:01pm
CORRESP
aua3vb af
16 Jan 24
Correspondence with SEC
12:00am
UPLOAD
b41si7qf2v
12 Jan 24
Letter from SEC
12:00am
4
x7e336sskphq1k8vjv
4 Jan 24
First Wave BioPharma / CHARLES J CASAMENTO ownership change
5:14pm